Russia plans to complete clinical trials of tuberculosis vaccine by end of 2026
Scientists intend to register it in 2027, Irina Vasilyeva, Director of the National Medical Research Center for Phthisiopulmonology and Infectious Diseases, says
Russia is working on a new tuberculosis vaccine. Clinical trials are expected to conclude by the end of 2026. The vaccine is slated for registration in 2027, according to Irina Vasilyeva, Director of the National Medical Research Center for Phthisiopulmonology and Infectious Diseases.
- Russia is developing a new tuberculosis vaccine.
- Clinical trials are scheduled to finish by the end of 2026.
- The vaccine is intended for registration in 2027.
- Irina Vasilyeva, Director of the National Medical Research Center for Phthisiopulmonology and Infectious Diseases, provided the information.
Write a comment